Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 6/20 | 0.35 |
| ▸ | CA1 | P00915 | 6/20 | 0.35 |
| ▸ | CA2 | P00918 | 6/20 | 0.35 |
| ▸ | CA9 | Q16790 | 6/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 3/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.34 |
| ▸ | LMNA | P02545 | 3/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1338978 | 1.00 | TSHR (0.50) | TSHRHCAR2TP53CA12CA1 | |
| SCHEMBL1336756 | 1.00 | TSHR (0.50) | TSHRHCAR2TP53CA12CA1 | |
| SCHEMBL8636434 | 1.00 | TSHR (0.50) | TSHRHCAR2TP53CA12CA1 | |
| SCHEMBL5482220 | 0.89 | TSHR (0.50) | TSHRHCAR2TP53CA12CA1 | |
| SCHEMBL7438737 | 0.89 | TSHR (0.42) | TSHRHCAR2CA12CA1CA2 | |
| SCHEMBL12951517 | 0.88 | TSHR (0.46) | TSHRHCAR2TP53CA12CA1 | |
| SCHEMBL882439 | 0.88 | TSHR (0.46) | TSHRHCAR2TP53CA12CA1 | |
| SCHEMBL2246643 | 0.86 | TSHR (0.43) | TSHRHCAR2TP53CA12CA1 | |
| SCHEMBL2244398 | 0.86 | TSHR (0.43) | TSHRHCAR2TP53CA12CA1 | |
| SCHEMBL8272086 | 0.86 | TSHR (0.43) | TSHRHCAR2TP53CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1333 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144726-A1 | POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | L'OREAL (FR) | 2026-05-28 | — | — | US | claimed |
| US-12252483-B2 | Method for producing optically active 1, 4-benzothiazepine-1-oxide derivative | AETAS PHARMA CO., LTD. (JP) | 2025-03-18 | — | — | US | claimed |
| CN-119638969-A | Degradable aromatic polyester polymer and synthesis method thereof | 青岛大学 | 2025-03-18 | — | — | CN | claimed |
| CN-119104658-A | Method for detecting valicarb-isopropyl tartrate genotoxic impurity D | 山东百诺医药股份有限公司 | 2024-12-10 | — | — | CN | claimed |
| CN-119016001-A | Micro-reaction system and method for synthesizing bio-based polyol | 中建安装集团有限公司 | 2024-11-26 | — | — | CN | claimed |
| CN-115505108-B | Hydrolysis-resistant titanium catalyst and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-117603047-B | Preparation method and application of bio-based polyol | 中建安装集团有限公司 | 2024-06-11 | — | — | CN | claimed |
| US-11958818-B2 | (R)-(2-methyloxiran-2-yl)methyl 4-bromobenzenesulfonate | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2024-04-16 | — | — | US | claimed |
| CN-117838769-A | Combined suppository of valicarb-isopropyl tartrate and houttuynia cordata and preparation method thereof | 湖北广济医药科技有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-115650787-B | Liquid compositions containing urease inhibitors | 甘肃云昊科技有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-1052668-A | The compound of treatment inflammatory bowel disease | LILLY CO ELI (US) | 1991-07-03 | — | — | CN | claimed |
| EP-0434394-A2 | Compounds for treating inflammatory bowel disease | ELI LILLY AND COMPANY (US) | 1991-06-26 | — | — | EP | claimed |
| EP-0417187-A1 | RUTHENIUM-CATALYZED PRODUCTION OF CYCLIC SULFATES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1991-03-20 | — | — | EP | claimed |
| WO-1989011478-A1 | RUTHENIUM-CATALYZED PRODUCTION OF CYCLIC SULFATES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1989-11-30 | — | — | WO | claimed |
| US-4764628-A | Asymmetric epoxidation of allylic alcohols | ARCO CHEMICAL COMPANY (US) | 1988-08-16 | — | — | US | claimed |
| WO-1988001612-A1 | PROCESSES AND INTERMEDIATES FOR N-(S-3-ALKYL-HEPTANOYL)-D-GAMMA-GLUTAMYL-GLYCYL-D-ALANINE | PFIZER INC. (US) | 1988-03-10 | — | — | WO | claimed |
| CN-87105898-A | N-(sProcess and intermediates for the preparation of -3-alkylheptanoyl -D-r-glutamyl -glycyl -D-alanyl | — | 1988-03-09 | — | — | CN | claimed |
| EP-0258032-A2 | Processes and intermediates for N-(S-3-alkylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine | PFIZER INC. (US) | 1988-03-02 | — | — | EP | claimed |
| EP-0129044-A1 | Synthesis of (+)-4-demethoxydaunomycinone | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1984-12-27 | — | — | EP | claimed |
| US-4489206-A | Synthesis of (+)-4-demethoxydaunomycinone | ADRIA LABORATORIES, INC. (US) | 1984-12-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12252483-B2 | Method for producing optically active 1, 4-benzothiazepine-1-oxide derivative | DUOX1, WNT1, CYP4Z1 | TSHR 3929/4885HCAR2 2709/4885TP53 4529/4885 |
| US-20260144726-A1 | POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | HAO2, HADH, LDHA | TSHR 1891/4885HCAR2 11/4885TP53 598/4885 |
| US-11958818-B2 | (R)-(2-methyloxiran-2-yl)methyl 4-bromobenzenesulfonate | CBR1, BRD4, DNMT1 | TSHR 1940/4885HCAR2 2236/4885TP53 2291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.